Neurocrine Biosciences, Inc.
MX ˙ BMV ˙ US64125C1099
SecurityMX:NBIX / Neurocrine Biosciences, Inc.
InstitutionCreative Planning
Latest Disclosed Ownership68,387 shares
Latest Disclosed Value $ 9,009,290
Creative Planning ownership in NBIX / Neurocrine Biosciences, Inc.

On May 12, 2026 - Creative Planning filed a 13F-HR form disclosing ownership of 68,387 shares of Neurocrine Biosciences, Inc. (MX:NBIX) valued at $9,009,290 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 53,266 shares of Neurocrine Biosciences, Inc.. This represents a change in shares of 28.39% during the quarter.

Creative Planning has a history of taking positions in derivatives of the underlying security (NBIX) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

MX:NBIX / Neurocrine Biosciences, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 68,387 15,121 28.39 9,009 19.26 0.0061
2026-02-17 2025-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 53,266 20,800 64.07 7,555 65.77 0.0054
2025-11-14 2025-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 32,466 18,221 127.91 4,558 154.58 0.0035
2025-08-08 2025-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 14,245 3,422 31.62 1,790 49.54 0.0015
2025-05-15 2025-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 10,823 -8,661 -44.45 1,197 -54.98 0.0011
2025-02-14 2024-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 19,484 6,485 49.89 2,660 77.62 0.0026
2024-10-11 2024-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 12,999 1,426 12.32 1,498 -6.03 0.0015
2024-08-15 2024-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 11,573 30 0.26 1,593 0.06 0.0017
2024-05-13 2024-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 11,543 1,829 18.83 1,592 24.47 0.0018
2024-02-14 2023-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 9,714 1,452 17.57 1,280 37.67 0.0024
2023-11-16 2023-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 8,262 841 11.33 929 32.90 0.0012
2023-07-21 2023-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 7,421 -101 -1.34 700 -8.15 0.0009
2023-05-15 2023-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 7,522 708 10.39 761 -6.40 0.0011
2023-02-10 2022-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 6,814 -492 -6.73 814 4.77 0.0012
2022-11-03 2022-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 7,306 2,164 42.08 776 54.89 0.0013
2022-08-15 2022-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 5,142 1,102 27.28 501 32.19 0.0008
2022-05-16 2022-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 4,040 -16 -0.39 379 9.86 0.0006
2022-02-11 2021-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 4,056 128 3.26 345 -8.49 0.0006
2021-11-10 2021-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 3,928 278 7.62 377 6.20 0.0007
2021-08-04 2021-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 3,650 -261 -6.67 355 -6.58 0.0006
2021-04-30 2021-03-31 13F CreativePlanning COM 64125C109 3,911 -2,394 -37.97 380 -37.09 0.0008
2021-01-29 2020-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 6,305 282 4.68 604 4.32 0.0013
2020-11-05 2020-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 6,023 459 8.25 579 -14.73 0.0015
2020-07-23 2020-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 5,564 125 2.30 679 44.16 0.0020
2020-05-05 2020-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 5,439 -59 -1.07 471 -20.30 0.0017
2020-01-30 2019-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 5,498 210 3.97 591 23.90 0.0018
2019-11-01 2019-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 5,288 20 0.38 477 7.19 0.0016
2019-07-26 2019-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 5,268 -115 -2.14 445 -6.12 0.0015
2019-04-24 2019-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 5,383 62 1.17 474 24.74 0.0017
2019-02-12 2018-12-31 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 5,321 23 0.43 380 -41.63 0.0016
2019-02-01 2018-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 5,321 23 380
2018-10-25 2018-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 5,298 280 5.58 651 32.05 0.0024
2018-07-20 2018-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 5,018 30 0.60 493 19.08 0.0019
2018-04-18 2018-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 4,988 20 0.40 414 7.53 0.0017
2018-01-17 2017-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 4,968 -20 -0.40 385 25.82 0.0017
2017-10-17 2017-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 4,988 -235 -4.50 306 27.50 0.0014
2017-07-12 2017-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 5,223 -143 -2.66 240 3.45 0.0012
2017-04-07 2017-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 5,366 -177 -3.19 232 7.91 0.0013
2017-01-09 2016-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 5,543 205 3.84 215 -20.37 0.0013
2016-10-12 2016-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 5,338 38 0.72 270 12.03 0.0017
2016-07-12 2016-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 5,300 0 0.00 241 14.76 0.0017
2016-04-08 2016-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 5,300 -5,400 -50.47 210 -65.29 0.0016
2016-01-11 2015-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 10,700 10,000 1,428.57 605 2,060.71 0.0050
2015-10-09 2015-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 700 -26,200 -97.40 28 -97.82 0.0002
2015-07-09 2015-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 26,900 26,600 8,866.67 1,285 10,608.33 0.0117
2015-04-13 2015-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 300 -200 -40.00 12 50.00 0.0001
2014-04-11 2014-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 500 0 0.00 8 60.00 0.0001
2014-01-06 2013-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 500 500 -88.89 5 -91.67 0.0001
2013-10-10 2013-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 0 -4,500 -100.00 0 -100.00
2013-07-09 2013-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 4,500 4,500 60 0.0014
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2020-11-05 2020-09-30 13F NEUROCRINE BIOSCIENCES COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-07-23 2020-06-30 13F NEUROCRINE BIOSCIENCES COM Call 100 1 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.